Tag Archives: astrazeneca

Developed in partnership with Oxford University, AstraZeneca’s Covid-19 vaccine was found to be 70.4 percent effective in a peer-reviewed study published in The Lancet medical journal on Tuesday. It may seem like a low number, compared to the roughly 95 percent effectiveness touted by rival firms Pfizer and Moderna, yet …

With over one-and-a-half million Covid-19 deaths and six million recorded cases worldwide, everyone is aware that the need for a vaccine to stop the spread of the virus is urgent. It has to be developed swiftly and safely, and target all age groups, particularly those at higher risk. The race …

The British-Swedish pharmaceutical giant is to run a fresh trial of its candidate vaccine at a lower dosage, which the company earlier claimed had performed better than a full dosage. “Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do …

The British-Swedish company, which has developed its candidate vaccine together with the University of Oxford, “will begin the submission of the clinical data to regulators around the world that have a framework in place for emergency use or conditional approval,” its spokesman said on Monday, adding that the list of …

On Monday, the pharmacological company announced that its AZD1222 vaccine for Covid-19, which is based on a common cold virus that causes infection in chimpanzees, has an efficacy of 70 percent. The number is average for two slightly different tests. One involved people, who received half a dose of the …

The developers revealed the preliminary results on Monday, following trials conducted in the UK and Brazil. Depending on the dosage, the vaccine showed varying efficiency of up to 90 percent, while the Pfizer vaccine is 95 percent effective and Russia’s Sputnik V is 92 percent effective. “One dosing regimen showed …

Brazil’s National Health Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria, ANVISA), said on Wednesday that it was informed of the death on October 19, along with a recommendation that the study be continued. Brazilian media did not identify the deceased by name, saying only that he was 28 years old …

The company published details of the trials on Saturday, after facing criticism over the lack of transparency surrounding the testing of the much-anticipated vaccine against the virus, which has so far infected more than 30.8 million people and caused over 958,000 fatalities worldwide. The first participant of the British trials …

A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN. Though the report …

AstraZeneca only said that its “standard review process triggered a pause to vaccination to allow review of safety data,” according to a statement by a company spokesperson on Tuesday. It was unclear whether the hold was self-imposed or ordered by a regulator, what the adverse reaction may have been, or …